
zzso zzso directed at zzso zzso have been used clinically since zzso In most of the completed clinical trials, the zzso were of zzso zzso Twenty-six of 184 patients zzso receiving zzso demonstrated a major clinical response, including 3 complete zzso zzso are primarily related to immune zzso The immune response triggering the toxic manifestations may be zzso by interactions between the administered zzso and the target zzso zzso or between the zzso and host zzso made in response to its zzso Analysis of the mechanism of action, zzso and toxicity of zzso administration should lead to improved design of clinical zzso and provide a basis for the use of human zzso and zzso zzso to zzso toxins or zzso zzso 

